Cargando…

Improving Cancer Care for Patients With CKD: The Need for Changes in Clinical Trials

Chemotherapeutic agents used to treat cancer generally have narrow therapeutic indices along with potentially serious adverse toxicities. Many cancer drugs are at least partially excreted through the kidney and, thus, the availability of accurate data on safe and effective dosing of these drugs in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sprangers, Ben, Perazella, Mark A., Lichtman, Stuart M., Rosner, Mitchell H., Jhaveri, Kenar D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458993/ https://www.ncbi.nlm.nih.gov/pubmed/36090489 http://dx.doi.org/10.1016/j.ekir.2022.06.005

Ejemplares similares

COVID-19 therapeutic options for patients with kidney disease
por: Izzedine, Hassan, et al.
Publicado: (2020)

Genes, COVID-19 and phenotype
por: Izzedine, Hassan, et al.
Publicado: (2021)

Revisiting the role of acute kidney injury in patients on immune checkpoint inhibitors: a good prognosis renal event with a significant impact on survival
por: García-Carro, Clara, et al.
Publicado: (2023)

Checkpoint inhibitor therapy-associated acute kidney injury: time to move on to evidence-based recommendations
por: Perazella, Mark A, et al.
Publicado: (2021)

Immune checkpoint inhibitor use in patients with end-stage kidney disease: an analysis of reported cases and literature review
por: Kitchlu, Abhijat, et al.
Publicado: (2021)

Risk factors associated with post–kidney transplant malignancies: an article from the Cancer-Kidney International Network
por: Sprangers, Ben, et al.
Publicado: (2018)

Acute kidney injury in the patient with cancer
por: Rosner, Mitchell H., et al.
Publicado: (2019)

Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Mellitus and CKD
por: Presswala, Lubaina, et al.
Publicado: (2019)

The Relationship Between Medication Discrepancies and Hospitalization Risk Among Patients With Advanced CKD
por: Sakhiya, Vipul, et al.
Publicado: (2019)

In Case of a Pandemic, Pivot: Moving the National Kidney Foundation Spring Clinical Meeting Online
por: Kramer, Holly, et al.
Publicado: (2021)

Cardio–renal service, time for a change
por: Uppal, Nupur N, et al.
Publicado: (2021)

Unmet needs for CKD care: from the general population to the CKD clinics—how many patients are we missing?
por: Torreggiani, Massimo, et al.
Publicado: (2021)

Awareness and knowledge among internal medicine house-staff for dose adjustment of commonly used medications in patients with CKD
por: Surana, Sikander, et al.
Publicado: (2017)

Home Dialysis in the Time of COVID-19: Reflections on Rapidly Changing Policies
por: Sachdeva, Mala, et al.
Publicado: (2020)

Does treating with anti–PD-1 to improve glomerular health come without a cost?
por: Jhaveri, Kenar D., et al.
Publicado: (2022)

A letter to the Master Clinician
por: Jhaveri, Kenar D.
Publicado: (2014)

CKD Express © - A New IT-Software Proposed for a Paradigm Change in CKD Care
por: Onuigbo, Macaulay AC
Publicado: (2012)

Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients
por: Sprangers, Ben, et al.
Publicado: (2020)

Unmet needs in clinical trials in CKD: questions we have not answered and answers we have not questioned
por: Levin, Adeera, et al.
Publicado: (2022)

Glomerular diseases post-hematopoietic stem cell transplantation: pathologic spectrum and plausible mechanisms
por: Caza, Tiffany N, et al.
Publicado: (2023)

Reversible Fanconi syndrome due to lenalidomide
por: Glezerman, Ilya G., et al.
Publicado: (2008)

Onconephrology abstracts and publication trends: time to collaborate
por: Thakkar, Jyotsana, et al.
Publicado: (2015)

Anaplastic lymphoma kinase inhibitors and their effect on the kidney
por: Bonilla, Marco, et al.
Publicado: (2022)

Nirogacestat and Hypophosphatemia
por: Gudsoorkar, Prakash, et al.
Publicado: (2023)

Podocyte puzzle: IgA nephropathy
por: Bharati, Joyita, et al.
Publicado: (2023)

Anticoagulation in CKD: Trials and Tribulations
por: Mohsen, Mai, et al.
Publicado: (2023)

A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial
por: Cooney, Danielle, et al.
Publicado: (2015)

Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates
por: Kawashima, Shun, et al.
Publicado: (2022)

Chief’s seminar: turning interns into clinicians
por: Dittus, Christopher, et al.
Publicado: (2014)

Paging Doctor Google! Heuristics vs. technology
por: Jhaveri, Kenar D, et al.
Publicado: (2013)

Enhancing outpatient nephrology experience for internal medicine residents
por: Agrawal, Varun, et al.
Publicado: (2017)

Renal effects of BRAF inhibitors: a systematic review by the Cancer and the Kidney International Network
por: Wanchoo, Rimda, et al.
Publicado: (2016)

Pembrolizumab-Associated Nerve Epidermal Growth Factor-Like 1 Membranous Nephropathy
por: Nimkar, Abhishek, et al.
Publicado: (2022)

Atypical Anti-Glomerular Basement Membrane Disease
por: Bharati, Joyita, et al.
Publicado: (2023)

Eliminating Missed Opportunities for CKD Care
por: Kramer, Holly, et al.
Publicado: (2019)

Acute Kidney Injury in the Patient with Cancer
por: Meraz-Munoz, Alejandro, et al.
Publicado: (2021)

Management of hypertension in patients with cancer: challenges and considerations
por: Pandey, Shubhi, et al.
Publicado: (2023)

Health information technology (IT) to improve the care of patients with chronic kidney disease (CKD)
por: Diamantidis, Clarissa J, et al.
Publicado: (2014)

Atrial Fibrillation and Longitudinal Change in Cognitive Function in CKD
por: McCauley, Mark D., et al.
Publicado: (2021)

Shedding a light on sex disparity in clinical trials in CKD patients
por: Mallamaci, Francesca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fa93h0a6nmccd2sion9m66ss20